2019
DOI: 10.1016/j.jdcr.2019.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Two cases of disseminated tuberculosis after negative screening before adalimumab treatment for immune-mediated inflammatory diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…IFN-c release assays are the current standard, but there is controversial evidence regarding their utility, 28,29 and improved testing is needed to minimize the risk of reactivated or disseminated disease. [30][31][32] When managing patients with a previous history of treated tuberculosis, it is essential to obtain documentation of completed therapy. Due to their previous exposure, both IGRA and TST results will be positive, making it necessary to monitor them through chest radiographs and clinical symptom assessment.…”
Section: Tb and Biologicsmentioning
confidence: 99%
See 1 more Smart Citation
“…IFN-c release assays are the current standard, but there is controversial evidence regarding their utility, 28,29 and improved testing is needed to minimize the risk of reactivated or disseminated disease. [30][31][32] When managing patients with a previous history of treated tuberculosis, it is essential to obtain documentation of completed therapy. Due to their previous exposure, both IGRA and TST results will be positive, making it necessary to monitor them through chest radiographs and clinical symptom assessment.…”
Section: Tb and Biologicsmentioning
confidence: 99%
“…These medications can compromise the immune system and activate latent tuberculosis infections. IFN‐γ release assays are the current standard, but there is controversial evidence regarding their utility, 28,29 and improved testing is needed to minimize the risk of reactivated or disseminated disease 30–32 . When managing patients with a previous history of treated tuberculosis, it is essential to obtain documentation of completed therapy.…”
Section: Diagnostics and Screeningmentioning
confidence: 99%